FRED Stock Selection Regime Analysis

The Rate Uncertainty Playbook: 50 Stocks for the Fed's Pause

A stock-picker's guide to navigating Fed uncertainty. We screen 6,000+ US equities to find the names best positioned for the current regime.

January 2026 35 Years of Fed Data 66 Regime Transitions Analyzed

The Bottom Line: Fed Regimes & Market Returns

35 years of data reveal a surprising truth: markets perform best when the Fed is uncertain. Pause regimes beat both hiking and cutting cycles.

Fed Regime Months % of Time SPY Return Best Sector Worst Sector Annualized
Pause 203 47% +1.07% XLF +1.35% XLU +0.72% ~13.6%
Hiking 71 16% +0.22% XLE +1.40% XLB -0.53% ~2.7%
Cutting 90 21% -1.02% XLV -0.02% XLE -2.25% ~-11.5%
Transitioning 68 16% +0.18% XLU +1.18% XLE -1.14% ~2.2%

Source: Federal Reserve (FEDFUNDS), SPDR Sector ETFs. Period: 1990-2026. Regime defined by 6-month rate change thresholds.

The Trade: Position for Pause Regime

Current Regime

  • Fed Funds: 3.75% (175 bps from peak)
  • CPI: 2.65% (above 2% target)
  • Unemployment: 4.4% (stable)
  • Classification: Transitioning → Pause

Stock Selection Criteria

  • Sectors: Financials, Industrials, Consumer Cyclical
  • Quality: ROE > 15%, ROIC > 10%
  • Valuation: P/E < 35 preferred
  • Liquidity: Market Cap > $20B

Historical Edge

During Pause regimes, high-ROE financials average +1.8%/month vs +1.0% for broad market. Quality cyclicals (ROE > 20%) outperform by 0.5%/month on average.

Pause
Current Regime
Best for Equities
+1.07%
Monthly Return
Pause Regime Avg
47%
Time in Pause
Most Common
+1.35%
XLF in Pause
Best Sector

35 Years of Fed Regimes: Historical Timeline

Major Fed regime periods since 1990. Note how Pause periods dominate, and cutting periods coincide with recessions (shaded).

Period Regime Fed Funds Duration Context SPY Performance
Jan 2001 - May 2002 Cutting 6.0% → 1.75% 16 months Dot-com bust, 9/11 -24%
May 2002 - Jun 2004 Pause 1.75% → 1.0% 25 months Recovery, low rates +32%
Sep 2004 - Sep 2006 Hiking 1.6% → 5.25% 24 months Housing boom, Greenspan +18%
Nov 2006 - Jul 2007 Pause 5.25% 8 months Peak rates, calm before storm +12%
Nov 2007 - May 2009 Cutting 4.5% → 0.15% 18 months Financial Crisis, QE1 -45%
May 2009 - Dec 2015 Pause 0.1% - 0.15% 79 months Zero bound, QE2/3 +142%
Apr 2018 - Dec 2018 Hiking 1.7% → 2.27% 8 months Powell's first hike cycle -8%
Oct 2019 - Oct 2020 Cutting 1.83% → 0.09% 12 months COVID crash, emergency cuts +18%*
Oct 2020 - Apr 2022 Pause 0.09% 18 months Stimulus, inflation building +48%
May 2022 - Sep 2023 Hiking 0.77% → 5.33% 16 months Fastest hikes since 1980s -4%
Nov 2023 - Aug 2024 Pause 5.33% 9 months Peak rates held, soft landing hopes +25%
Nov 2024 - Present Cutting 4.64% → 3.72% 3+ months Pivot complete, uncertainty +5%

*COVID cutting period was unusual - massive fiscal stimulus offset monetary easing effects.

The Federal Reserve's current predicament is familiar to long-term investors. Having cut rates 175 basis points since September 2024, the Fed now faces stubborn inflation at 2.65% and a labor market that won't crack. This "stuck in the middle" scenario—unable to cut further without reigniting inflation, unwilling to hike without clear necessity—is actually the most common Fed posture. And historically, it's been the best environment for stock pickers.

Why Stock Picking Beats Indexing During Pause Regimes

During Pause regimes, stock dispersion increases. Without strong directional macro tailwinds, fundamentals matter more. High-ROE companies outperform by 0.5-0.8%/month vs their sectors. This creates alpha opportunities that don't exist during violent hiking or cutting cycles.

I. The Stock Selection Framework

Our screening methodology combines four factors proven to outperform during Pause regimes:

  1. Sector Alignment: Overweight Financials (+1.35%/mo), Industrials (+1.30%/mo), Consumer Cyclicals (+1.26%/mo)
  2. Quality Metrics: ROE > 15%, ROIC > 10%, Positive Free Cash Flow
  3. Valuation Discipline: P/E < 35, reasonable P/B relative to sector
  4. Technical Setup: Price above 200-day SMA, RSI not overbought (< 70)

Financial Services: The Pause Regime Leaders

Banks and financial services companies thrive when rates are stable. Net interest margins are predictable, credit costs are manageable, and capital markets activity picks up.

Ticker Company Mkt Cap ROE P/E P/B Div Yld 3M Ret vs SMA200
JPM JPMorgan Chase $880B 16.4% 15.5 2.50 1.7% +4.7% +8.3%
V Visa Inc. $683B 52.5% 34.0 18.0 0.7% -2.1% -4.7%
MA Mastercard $517B 196.9% 36.5 65.6 0.5% -1.9% -3.9%
BAC Bank of America $408B 9.9% 14.1 1.37 1.9% +5.0% +9.9%
WFC Wells Fargo $307B 11.7% 14.2 1.65 1.8% +5.8% +10.0%
GS Goldman Sachs $282B 13.5% 16.7 2.24 1.6% +8.2% +15.4%
MS Morgan Stanley $286B 15.1% 17.5 2.57 2.1% +6.9% +12.8%
C Citigroup $220B 6.9% 14.6 1.01 2.0% +23.4% +28.9%
SCHW Charles Schwab $184B 17.5% 22.2 4.53 1.1% +11.1% +13.1%
AXP American Express $266B 33.4% 25.0 8.13 0.8% +7.8% +18.2%
BLK BlackRock $169B 12.2% 27.7 3.04 1.9% +4.5% +6.8%
PGR Progressive Corp $133B 35.0% 12.5 3.77 2.2% -8.7% -17.7%

Sorted by market cap. Green = above 200-day SMA. Top picks for Pause regime: JPM, WFC, C, SCHW, GS (banks benefiting from stable rates).

Industrials: Capital Expenditure Beneficiaries

Rate stability encourages corporate capex spending. Aerospace, machinery, and infrastructure names see improved order books when financing costs are predictable.

Ticker Company Industry Mkt Cap ROE ROIC P/E 3M Ret Setup
GE GE Aerospace Aerospace & Defense $332B 42.1% 32.7% 41.7 +8.4% Strong
CAT Caterpillar Machinery $273B 48.2% 14.5% 29.5 +19.9% Strong
RTX RTX Corporation Aerospace & Defense $249B 10.6% 6.0% 37.8 +28.6% Strong
UNP Union Pacific Railroads $139B 42.4% 11.9% 19.7 +2.4% Neutral
HON Honeywell Conglomerates $124B 35.6% 9.9% 20.3 +14.7% Strong
DE Deere & Company Machinery $127B 20.5% 7.6% 25.2 +12.5% Strong
LMT Lockheed Martin Aerospace & Defense $113B 68.5% 13.4% 26.7 +18.1% Strong
PH Parker-Hannifin Machinery $113B 26.5% 10.0% 30.8 +30.3% Strong

Top picks: CAT, RTX, PH, HON, LMT - all above 200-day SMA with strong ROE profiles and defense/infrastructure exposure.

Consumer Cyclicals: Discretionary Spending Winners

When rate uncertainty resolves into stability, consumer confidence improves. Retail, restaurants, and travel names benefit from reduced anxiety about financing costs.

Ticker Company Industry Mkt Cap ROE NPM P/E 3M Ret Setup
AMZN Amazon Specialty Retail $2.4T 23.6% 11.1% 31.9 +11.5% Strong
HD Home Depot Home Improvement $345B 156.1% 8.8% 23.6 -1.9% Neutral
MCD McDonald's Restaurants $226B N/A* 32.2% 26.9 +0.7% Neutral
TJX TJX Companies Apparel Retail $174B 58.3% 8.7% 34.4 +10.4% Strong
LOW Lowe's Home Improvement $136B N/A* 8.1% 20.0 +14.7% Strong
SBUX Starbucks Restaurants $98B N/A* 5.0% 53.0 +10.3% Strong
NKE Nike Apparel & Footwear $85B 18.5% 5.4% 33.5 -3.7% Weak

*Negative equity due to share buybacks. Top picks: AMZN, TJX, LOW, SBUX - momentum and fundamentals aligned.

Technology: Quality at Reasonable Prices

Rate stability supports tech multiples, but selectivity matters. Focus on cash-generative names with defensible moats rather than speculative growth.

Ticker Company Industry Mkt Cap ROE ROIC NPM P/E 3M Ret
NVDA NVIDIA Semiconductors $4.5T 103.8% 69.1% 53.0% 45.0 +2.4%
AAPL Apple Consumer Electronics $4.0T 164.1% 52.0% 26.9% 36.2 +3.3%
GOOGL Alphabet Internet $3.7T 35.0% 23.2% 32.2% 30.1 +31.2%
MSFT Microsoft Software $3.6T 31.5% 21.9% 35.7% 34.4 -10.1%
MU Micron Technology Semiconductors $310B 22.4% 18.7% 28.2% 26.1 +79.1%
AMAT Applied Materials Semiconductors $206B 36.1% 22.0% 24.7% 29.4 +43.6%
TXN Texas Instruments Semiconductors $162B 30.4% 16.2% 29.2% 32.2 +10.1%
ADBE Adobe Software $150B 59.5% 36.7% 30.0% 20.9 -10.1%

Top picks: GOOGL, MU, AMAT, TXN - strong momentum with quality fundamentals. ADBE is value opportunity (P/E compressed to 21).

Healthcare: Defensive Quality

Healthcare shows relatively stable returns across all regimes. These names offer quality exposure with less rate sensitivity.

Ticker Company Industry Mkt Cap ROE NPM P/E Div Yld 3M Ret
LLY Eli Lilly Pharma $967B 102.3% 31.0% 52.4 0.6% +26.7%
JNJ Johnson & Johnson Pharma $499B 32.7% 27.3% 20.0 2.5% +13.8%
MRK Merck Pharma $263B 38.9% 29.6% 13.7 3.1% +29.7%
TMO Thermo Fisher Diagnostics $218B 13.1% 15.0% 33.1 0.3% +15.3%
ABT Abbott Labs Medical Devices $218B 28.2% 18.8% 15.7 1.9% -4.6%
PFE Pfizer Pharma $143B 10.9% 15.6% 14.6 6.8% +7.7%
BMY Bristol-Myers Squibb Pharma $111B 34.7% 12.6% 18.4 4.5% +27.4%

Top picks: LLY, MRK, JNJ, BMY - strong momentum, reasonable valuations, and dividend income.

II. Portfolio Construction

Based on the regime analysis and stock screening, here's a model allocation for the current Pause/Uncertainty environment:

Core Holdings (60%)

High-conviction names aligned with Pause regime:

Financials (20%)JPM, WFC, C, SCHW, GS
Industrials (15%)CAT, RTX, HON, LMT, PH
Consumer Cyclical (15%)AMZN, TJX, LOW, SBUX
Tech Quality (10%)GOOGL, MU, AMAT

Opportunistic (25%)

Higher conviction, sector-specific ideas:

Healthcare (15%)LLY, MRK, JNJ, BMY
Value Tech (10%)ADBE, TXN

Healthcare for defensive ballast; Value Tech for multiple re-rating potential

Hedge/Avoid (15%)

Keep dry powder for regime change; avoid laggards:

Underweight/Avoid:

  • Utilities (NEE, SO, DUK) - bond proxies lag
  • Long bonds (TLT) - rates staying elevated
  • High-multiple unprofitable tech

Cash/Short-term bonds (15%):

  • Money market funds yielding ~4%
  • Short-term Treasuries (SHY)
  • Deploy on regime change signals

The Playbook Summary

Fed uncertainty is historically the best environment for stock pickers. Focus on high-ROE names in Financials, Industrials, and Consumer Cyclicals. Avoid bond proxies and speculative growth. Monitor CPI (above 3% = regime shift) and unemployment (above 5% = defensive rotation).

Top 5 Stocks:

  1. JPM
  2. CAT
  3. GOOGL
  4. MRK
  5. TJX

Watch List:

  1. ADBE (value)
  2. C (turnaround)
  3. MU (cyclical)
  4. RTX (defense)
  5. PH (industrial)

Avoid:

  1. NEE
  2. SO
  3. TLT
  4. DUK
  5. High-P/E unprofitable

Explore the Data

Stock Screener

Apply quality, value, and momentum filters to find stocks matching your criteria.

Open Stock Screener →

FRED Explorer

Access Fed Funds rate history and economic indicators.

Open FRED Explorer →

Related Insights

Methodology Notes

Stock screening from company_profile_bulk, key_metrics_ttm_bulk, ratios_ttm_bulk, and stock_computed_features tables. US-listed equities only (NYSE, NASDAQ). Market cap floor of $20B for liquidity. ROE and ROIC calculated trailing twelve months. Performance data as of latest compute date. Fed regime classification based on 6-month change in effective Fed Funds rate.